GLP-1 is continuing to grab headlines as the huge uptake redefines luxury dining but not how you might think.
By 2030, as many as 70 million people are expected to be using GLP-1 medications, according to McKinsey & Company—a number large enough to fundamentally reshape not just health, but how the world eats, drinks and dines, as well as luxury dining.
There’s a subtle but powerful shift unfolding across the world’s most stylish restaurants, and it’s being driven not by chefs, but by the changing physiology and priorities of their guests. The rise of GLP-1 medications is reshaping how affluent women, in particular, are approaching food, wellness and indulgence. This isn’t about dining less—it’s about dining better, more selectively, and with intention.
Recent insights reported by Nation’s Restaurant News reveal that while GLP-1 users may be eating smaller quantities, they are not necessarily spending less when dining out. In many cases, they are maintaining—or even increasing—their spend per visit. The difference lies in what ends up on the table.
Across global culinary capitals—from Paris to London, New York City and back home in Sydney—menus are being navigated differently.
Where once it was about multi-course indulgence, today’s luxury diner is choosing with intention: a perfectly laminated croissant at Cédric Grolet Opéra, a single, exquisitely executed plant-based dish at Eleven Madison Park, a nutrient-dense smoothie or clean breakfast at Erewhon, or a beautifully brewed tea ritual at Sketch.
There is a noticeable move away from excess—fewer heavy dishes, less alcohol, and more interest in foods that align with energy, longevity and skin health.
This shift is particularly relevant for women over 35, who are increasingly prioritising how they feel after a meal, not just the experience itself. Dining out remains a cornerstone of the luxury lifestyle, but the motivation has evolved. It is no longer about volume—it is about atmosphere, design, service and emotional connection.
A single standout dish in a beautifully considered space now holds more appeal than a long, heavy tasting menu.
As McKinsey notes: “The restaurants that succeed over the next several years [will] be the ones willing to ask harder questions about who they’re trying to serve, what experience they’re really offering, and which outdated axioms they need to unlearn to get there.” This “unlearning” is already underway.
Forward-thinking restaurants are quietly adapting with smaller, more refined portions that do not feel restrictive, higher-protein and lighter menus that support energy and satiety, flexible ordering formats, and elevated non-alcoholic options—from botanical spritzes to functional drinks.
At the same time, McKinsey’s latest Next Normal insights point to a deeper transformation, where wellness converges with technology. AI-driven personalisation, automated kitchens and data-led menu curation are set to redefine the dining experience entirely.
Imagine arriving at a restaurant in Singapore or Tokyo where your preferences—lighter meals, minimal alcohol, high-protein choices—are already understood and subtly reflected in your menu. This is not a distant concept; it is already beginning to take shape.
For the modern luxury traveller, this shift is significant. GLP-1 is not diminishing the joy of food—it is refining it. It is about choosing quality over quantity, feeling energised rather than depleted, and aligning dining with wellness rather than undoing it. Luxury is no longer defined by excess, but by precision, intention and how something makes you feel long after you leave the table.
The future of dining will belong to restaurants that understand this new mindset. Because the modern diner is no longer asking “What can I have?” but rather, “What is worth it?”
